National Institute of Malaria Research, Indian Council of Medical Research, New Delhi, India.
Acta Trop. 2012 Mar;121(3):267-73. doi: 10.1016/j.actatropica.2011.11.008. Epub 2011 Nov 28.
Malaria is a major public health problem in India and one which contributes significantly to the overall malaria burden in Southeast Asia. The National Vector Borne Disease Control Program of India reported ∼1.6 million cases and ∼1100 malaria deaths in 2009. Some experts argue that this is a serious underestimation and that the actual number of malaria cases per year is likely between 9 and 50 times greater, with an approximate 13-fold underestimation of malaria-related mortality. The difficulty in making these estimations is further exacerbated by (i) highly variable malaria eco-epidemiological profiles, (ii) the transmission and overlap of multiple Plasmodium species and Anopheles vectors, (iii) increasing antimalarial drug resistance and insecticide resistance, and (iv) the impact of climate change on each of these variables. Simply stated, the burden of malaria in India is complex. Here we describe plans for a Center for the Study of Complex Malaria in India (CSCMi), one of ten International Centers of Excellence in Malaria Research (ICEMRs) located in malarious regions of the world recently funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The CSCMi is a close partnership between Indian and United States scientists, and aims to address major gaps in our understanding of the complexity of malaria in India, including changing patterns of epidemiology, vector biology and control, drug resistance, and parasite genomics. We hope that such a multidisciplinary approach that integrates clinical and field studies with laboratory, molecular, and genomic methods will provide a powerful combination for malaria control and prevention in India.
疟疾是印度的一个主要公共卫生问题,也是东南亚整体疟疾负担的重要组成部分。印度国家病媒传播疾病控制计划报告称,2009 年有 160 万例病例和 1100 例疟疾死亡。一些专家认为,这是一个严重的低估,实际每年的疟疾病例数可能是报告数的 9 到 50 倍,疟疾相关死亡率则被低估了约 13 倍。由于以下几个因素,这些估计更加困难:(i)疟疾生态流行病学特征高度可变;(ii)多种疟原虫和按蚊媒介的传播和重叠;(iii)抗疟药物和杀虫剂耐药性的增加;以及(iv)气候变化对这些变量的影响。简单地说,印度的疟疾负担非常复杂。在这里,我们描述了在印度建立复杂疟疾研究中心(CSCMi)的计划,该中心是美国国立过敏和传染病研究所(NIAID)和美国国立卫生研究院(NIH)最近资助的十个国际疟疾卓越研究中心(ICEMRs)之一,位于世界上疟疾流行的地区。CSCMi 是印度和美国科学家之间的密切合作伙伴关系,旨在解决我们对印度疟疾复杂性认识方面的主要差距,包括不断变化的流行病学、媒介生物学和控制、耐药性以及寄生虫基因组学模式。我们希望这种多学科方法,将临床和现场研究与实验室、分子和基因组方法相结合,将为印度的疟疾控制和预防提供强大的组合。